Advertisement
Advertisement
Recomlyse

Recomlyse Indications/Uses

tenecteplase

Manufacturer:

CSPC Pharma
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
Recomlyse is indicated in adults for the thrombolytic treatment of suspected myocardial infarction with persistent ST elevation or recent left Bundle Branch Block within 6 hours after the onset of acute myocardial infarction (AMI) symptoms.
Recomlyse is indicated for the thrombolytic treatment of the acute ischaemic stroke (AIS).
Intracranial hemorrhage must be ruled out through appropriate imaging examinations (such as head CT scan or other imaging diagnostic methods sensitive to bleeding) in advance, and treatment should be carried out as soon as possible within 4.5 hours after the onset of acute ischemic stroke symptoms.
The treatment effect is time-dependent; therefore, earlier treatment increases the probability of a favourable outcome.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement